KFKatherine Freeman

Katherine Freeman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katherine Freeman has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Scoping Review of Maternal Substance Use and Peer Support and Its Implications for Maternal Health Providers

    by Heather Howard, Katherine Freeman, Sarvika Bommakanti, Jiong Gao

    Background: The number of pregnant and postpartum women with opioid use disorder (PPWOUD) quadrupled since 1999, signifying a public health crisis. Objectives: This scoping review examined the strength and consistency of findings in medical and social science literature regarding maternal recovery, capacity, and mortality from overdose, and the influence of recovery peer support specialists (RPSS). Inclusion Criteria: Study designs included clinical trials, cohort studies, case reports, case series, historical controls, and qualitative research and encompassed quantitative, qualitative, and mixed‐methods studies. Excluded were studies with medication as the sole treatment for OUD, neonatal outcomes only, mortality specific to self‐harm, and studies based outside the United States. Five authors independently evaluated inclusion criteria, extracted data, and assessed quality. Search Strategy: PubMed, CINAHL, OneSearch, Clinicaltrials.gov , WHO, Embase, and Cochrane Review were searched from January 2000 to August 2021, with results reviewed between June and August 2021. Study Selection: Diverse study designs were used (observational cohorts, retrospective and prospective cohorts, cross‐sectional studies, randomized trial protocols, and systematic reviews) across quantitative, qualitative, and mixed‐methods approaches, organizing them within an eco‐systems framework spanning pregnancy through 12 months postpartum to assess maternal recovery, capacity, and opioid‐related mortality (Aims 1–3) and to contextualize these outcomes within the broader public health crisis and potential role of RPSS (Aim 4). Data Extraction: Demographics, covariates, sources of bias, and effect size were compiled according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis extension for Scoping Reviews (PRISMA‐ScR) statement. Fourteen studies met inclusion criteria with the eco‐systems framework. Results: Aim 1, maternal recovery: early medication for OUD and mental health disorders, patient navigator, and RPSS had positive outcomes. Aim 2, maternal capacity: parental support was impactful, with external stigma and separation from their child having a negative impact. Aim 3, maternal mortality from opioid overdose: infant removal and untreated mental health were contributing factors. Aim 4, perceived effectiveness of RPSS: RPSS may support maternal recovery and capacity and reduce mortality from overdose, albeit the paucity of research. Conclusions: RPSS positioned to support PPWOUD may aid in effectively addressing this public health concern. Incorporating anti‐oppressive practices and promoting agency for PPWOUD would increase access to services. Recommendations are to invest in research on recovery, emphasizing mental health, early treatment, and peer support to help coordinate and facilitate mental health services.

  • Open Access

    Bridging the Gap: Enhancing the Generalizability of Clinical Trial Findings

    by Andre Williams, Cassandre Horne, Katherine Freeman

    Clinical research is a multifaceted and arduous undertaking characterized by numerous components, such as participant recruitment and engagement, the complexity of the research process, and the potential for bias. A critical concern in the conduct of clinical trials is the underrepresentation of essential population groups, which undermines external validity and limits the capacity to extrapolate results to broader and more diverse populations. This report outlines strategies for enhancing representation, including comprehensive methods to improve demographic representation and advanced statistical methodologies. The objective of this report is to examine detailed strategies for enhancing the representation of groups that are often underrepresented in clinical trials, including meticulous approaches for data collection and study reporting. These strategies ensure that results maintain both scientific rigor and representativeness of the populations most pertinent to the research question.Integral to this discourse is the examination of the contributions of Artificial Intelligence and Machine Learning in advancing the success of clinical trials. Artificial Intelligence and Machine Learning techniques are utilized to optimize study planning and data analysis, accompanied by a cautionary note regarding the potential for algorithmic bias. This report provides insights and a methodological framework to improve the generalizability of clinical trial outcomes, exploring the ramifications for scientific integrity and healthcare policy.

  • Open Access

    Driver vehicle crashes and mental health challenges among commuter college students

    by Louis A. Merlin, David A. Simpson, Katherine Freeman, Serena Hoermann, John Renne


  • Open Access

    Community Engagement Methods Related to Veteran Studies: A Scoping Review

    by Ayse Torres, Katherine Freeman-Costin, Kenneth M. Frankel, Danica Garbett

    Community engagement in research enhances a community's ability to address its own needs and challenges while ensuring that researchers understand community priorities. Some confusion exists about the definition of community engagement in the context of veteran research. The purpose of this study was to search the literature to identify common applications of community engagement in U.S. veterans’ research and to determine how and at what stage veterans were involved in the research process. A systematic scoping review was conducted using CINAHL Plus, Wiley Cochrane Library, Education Source, ERIC, APA PsycInfo, National Library of Medicine PubMed, ProQuest Social Services Abstracts, and SocIndex by two independent investigators. Forty-two of 1,977 studies from initial searches were included in this review. From these studies, we identified two aspects of veterans’ involvement in research characterized as “community engagement”: (a) veterans as participants and (b) veterans as partners in the research process. There is a need to encourage veterans’ engagement and to standardize reporting of their engagement in the various phases of the research process.

  • Open Access

    Associations between Florida counties’ COVID-19 case and death rates and meaningful use among Medicaid providers: Cross-sectional ecologic study

    by Katherine Freeman, Judith P. Monestime

    Although the Health Information Technology for Economic and Clinical Health (HITECH) Act has accelerated adoption of Electronic Health Records (EHRs) among Medicaid providers, only half achieved Meaningful Use. Furthermore, Meaningful Use’ impact on reporting and/or clinical outcomes remains unknown. To address this deficit, we assessed the difference between Medicaid providers who did and did not achieve Meaningful Use regarding Florida county-level cumulative COVID-19 death, case and case fatality rates (CFR), accounting for county-level demographics, socioeconomic and clinical markers, and healthcare environment. We found that cumulative incidence rates of COVID-19 deaths and CFRs were significantly different between the 5025 Medicaid providers not achieving Meaningful Use and the 3723 achieving Meaningful Use (mean 0.8334/1000 population; SD = 0.3489 vs. mean = 0.8216/1000; SD = 0.3227, respectively) (P = .01). CFRs were .01797 and .01781, respectively, P = .04. County-level characteristics independently associated with increased COVID-19 death rates and CFRs include greater concentrations of persons of African American or Black race, lower median household income, higher unemployment, and higher concentrations of those living in poverty and without health insurance (all P < .001). In accordance with other studies, social determinants of health were independently associated with clinical outcomes. Our findings also suggest that the association between Florida counties’ public health outcomes and Meaningful Use achievement may have had less to do with using EHRs for reporting of clinical outcomes and more to do with using EHRs for coordination of care—a key measure of quality. The Florida Medicaid Promoting Interoperability Program which incentivized Medicaid providers towards achieving Meaningful Use, has demonstrated success regarding both rates of adoption and clinical outcomes. Because the Program ends in 2021, we support programs such as HealthyPeople 2030 Health IT which address the remaining half of Florida Medicaid providers who have not yet achieved Meaningful Use.


  • Open Access

    Single Word Intelligibility of Individuals with Parkinson’s Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC)

    by Geralyn Schulz, Angela Halpern, Jennifer Spielman, Lorraine Ramig, Ira Panzer, Alan Sharpley, Katherine Freeman

    The majority of people with Parkinson’s disease (PD) experience both prosodic changes (reduced vocal volume, reduced pitch range) and articulatory changes (imprecise articulation) that often limit speech intelligibility and may contribute to significant declines in quality of life. We conducted a randomized control trial comparing two intensive treatments, voice (LSVT LOUD) or articulation (LSVT ARTIC) to assess single word intelligibility in the presence of background noise (babble and mall). Participants (64 PD and 20 Healthy) read words from the diagnostic rhyme test (DRT), an ANSI Standard for measuring intelligibility of speech, before and after one month (treatment or no treatment). Teams of trained listeners blindly rated the data. Speech intelligibility of words in the presence of both noise conditions improved in PD participants who had LSVT LOUD compared to the groups that had LSVT ARTIC or no treatment. Intensive speech treatment targeting prominent prosodic variables in LSVT LOUD had a positive effect on speech intelligibility at the single word level in PD.


  • Open Access

    Association Between Meaningful Use and Florida Counties’ COVID-19 Case and Death Rates Among Medicaid Providers (Preprint)

    by Katherine Freeman, Judith P. Monestime

    BACKGROUND Although the Health Information Technology for Economic and Clinical Health (HITECH) Act has accelerated the adoption of Meaningful Use of Electronic Health Records (EHRs) among Medicaid providers, only about half achieve Meaningful Use. Furthermore, the validity of public health reporting of COVID-19 outcomes, which relies on Meaningful Use advanced functions, remains unknown. OBJECTIVE This study aims to examine the difference between Medicaid providers who did and did not achieve Meaningful Use regarding Florida county-level incidence rates of COVID-19 cases and deaths, accounting for county-level race/ethnicity, unemployment, income, prevalence of respiratory diseases, age, poverty, and healthcare environment. METHODS This cross-sectional ecologic study examined the association between Meaningful Use achievement by Medicaid providers and COVID-19 cases and death rates from 67 Florida counties as of November 19, 2020. Provider information was obtained from the publicly available database from the Florida Medicaid Promoting Interoperability Program, formerly Electronic Health Record Incentive Program. The database includes the Area Health Resources File, capturing provider characteristics and population demographic and socioeconomic characteristics at the county level. Cumulative COVID-19 cases and deaths were obtained from the Florida Department of Health Open Data (FDOH) for zip codes which were aggregated by county. Rates were obtained by dividing cumulative incidence or prevalence by the U.S. Census County population. RESULTS As of November 19, 2020, the cumulative incidence rate of COVID-19 deaths was significantly different between Medicaid providers who achieved Meaningful Use and those who did not (P=.0131), with relatively more deaths reported for those not achieving Meaningful Use. County-level characteristics associated with increased COVID-19 death rates in hierarchical models include greater concentrations of persons of African American or Black race (P<.0001), lower median household income (P<.0001), higher unemployment (P<.0001), and higher concentrations of those living in poverty (P<.0001) and without health insurance (P<.0001). CONCLUSIONS Although Federal subsidies successfully influenced the adoption of Electronic Health Records, our findings suggest an emerging further digital "advanced use" divide among patients cared for by Medicaid providers. Policy interventions need to be reevaluated to address disparities in COVID-19 clinical outcomes which appear exacerbated by the limited use of advanced Electronic Health Records functions. CLINICALTRIAL not applicable

  • Open Access

    Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial

    by Tarsha Jones, Ashlee Guzman, Thomas Silverman, Katherine Freeman, Rita Kukafka, Katherine Crew

    Background: Chemopreventive agents such as selective estrogen receptor modulators and aromatase inhibitors have proven efficacy in reducing breast cancer risk by 41% to 79% in high-risk women. Women at high risk of developing breast cancer face the complex decision of whether to take selective estrogen receptor modulators or aromatase inhibitors for breast cancer chemoprevention. RealRisks is a patient-centered, web-based decision aid (DA) designed to promote the understanding of breast cancer risk and to engage diverse women in planning a preference-sensitive course of decision making about taking chemoprevention. Objective: This study aims to understand the perceptions of women at high risk of developing breast cancer regarding their experience with using RealRisks—a DA designed to promote the uptake of breast cancer chemoprevention—and to understand their information needs. Methods: We completed enrollment to a randomized controlled trial among 300 racially and ethnically diverse women at high risk of breast cancer who were assigned to standard educational materials alone or such materials in combination with RealRisks. We conducted semistructured interviews with a subset of 21 high-risk women enrolled in the intervention arm of the randomized controlled trial who initially accessed the tool (on average, 1 year earlier) to understand how they interacted with the tool. All interviews were audio recorded, transcribed verbatim, and compared with digital audio recordings to ensure the accuracy of the content. We used content analysis to generate themes. Results: The mean age of the 21 participants was 58.5 (SD 10.1) years. The participants were 5% (1/21) Asian, 24% (5/21) Black or African American, and 71% (15/21) White; 10% (2/21) of participants were Hispanic or Latina. All participants reported using RealRisks after being granted access to the DA. In total, 4 overarching themes emerged from the qualitative analyses: the acceptability of the intervention, specifically endorsed elements of the DA, recommendations for improvements, and information needs. All women found RealRisks to be acceptable and considered it to be helpful (21/21, 100%). Most women (13/21, 62%) reported that RealRisks was easy to navigate, user-friendly, and easily accessible on the web. The majority of women (18/21, 86%) felt that RealRisks improved their knowledge about breast cancer risk and chemoprevention options and that RealRisks informed their (17/21, 81%) decision about whether or not to take chemoprevention. Some women (9/21, 43%) shared recommendations for improvements, as they wanted more tailoring based on user characteristics, felt that the DA was targeting a narrow population of Hispanic or Latina by using graphic novel–style narratives, wanted more understandable terminology, and felt that the tool placed a strong emphasis on chemoprevention drugs. Conclusions: This qualitative study demonstrated the acceptability of the RealRisks web-based DA among a diverse group of high-risk women, who provided some recommendations for improvement.


  • Open Access

    Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial (Preprint)

    by Tarsha Jones, Ashlee Guzman, Thomas Silverman, Katherine Freeman, Rita Kukafka, Katherine Crew

    BACKGROUND Chemopreventive agents such as selective estrogen receptor modulators and aromatase inhibitors have proven efficacy in reducing breast cancer risk by 41% to 79% in high-risk women. Women at high risk of developing breast cancer face the complex decision of whether to take selective estrogen receptor modulators or aromatase inhibitors for breast cancer chemoprevention. RealRisks is a patient-centered, web-based decision aid (DA) designed to promote the understanding of breast cancer risk and to engage diverse women in planning a preference-sensitive course of decision making about taking chemoprevention. OBJECTIVE This study aims to understand the perceptions of women at high risk of developing breast cancer regarding their experience with using RealRisks—a DA designed to promote the uptake of breast cancer chemoprevention—and to understand their information needs. METHODS We completed enrollment to a randomized controlled trial among 300 racially and ethnically diverse women at high risk of breast cancer who were assigned to standard educational materials alone or such materials in combination with RealRisks. We conducted semistructured interviews with a subset of 21 high-risk women enrolled in the intervention arm of the randomized controlled trial who initially accessed the tool (on average, 1 year earlier) to understand how they interacted with the tool. All interviews were audio recorded, transcribed verbatim, and compared with digital audio recordings to ensure the accuracy of the content. We used content analysis to generate themes. RESULTS The mean age of the 21 participants was 58.5 (SD 10.1) years. The participants were 5% (1/21) Asian, 24% (5/21) Black or African American, and 71% (15/21) White; 10% (2/21) of participants were Hispanic or Latina. All participants reported using RealRisks after being granted access to the DA. In total, 4 overarching themes emerged from the qualitative analyses: the acceptability of the intervention, specifically endorsed elements of the DA, recommendations for improvements, and information needs. All women found RealRisks to be acceptable and considered it to be helpful (21/21, 100%). Most women (13/21, 62%) reported that RealRisks was easy to navigate, user-friendly, and easily accessible on the web. The majority of women (18/21, 86%) felt that RealRisks improved their knowledge about breast cancer risk and chemoprevention options and that RealRisks informed their (17/21, 81%) decision about whether or not to take chemoprevention. Some women (9/21, 43%) shared recommendations for improvements, as they wanted more tailoring based on user characteristics, felt that the DA was targeting a narrow population of Hispanic or Latina by using graphic novel–style narratives, wanted more understandable terminology, and felt that the tool placed a strong emphasis on chemoprevention drugs. CONCLUSIONS This qualitative study demonstrated the acceptability of the RealRisks web-based DA among a diverse group of high-risk women, who provided some recommendations for improvement. CLINICALTRIAL